NFSG
AMPE

Newbridge Financial Services Group’s Ampio Pharmaceuticals Inc. AMPE Stock Holding History

Newbridge Financial Services Group’s Portfolio AMPE Stock Details AMPE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-35
Closed -$32 – 1255
2024
Q1 		$32 Hold
35
– – ﹤0.01% 1162
2023
Q4 		$72 Hold
35
– – ﹤0.01% 1093
2023
Q3 		$127 Buy
35
+2
+6% +$9 ﹤0.01% 1246
2023
Q2 		$156 Hold
33
– – ﹤0.01% 1295
2023
Q1 		$156 Hold
33
– – ﹤0.01% 1355
2022
Q4 		$150 Hold
33
– – ﹤0.01% 1394
2022
Q3 		$1K Hold
33
– – ﹤0.01% 1366
2022
Q2 		$2K Hold
33
– – ﹤0.01% 1239
2022
Q1 		$5K Hold
33
– – ﹤0.01% 1124
2021
Q4 		$6K Buy
33
+11
+50% +$4.1K ﹤0.01% 1054
2021
Q3 		$11K Hold
22
– – 0.01% 861
2021
Q2 		$11K Buy
22
+5
+29% +$2.69K 0.01% 972
2021
Q1 		$8K Buy
17
+10
+143% +$5.16K 0.01% 969
2020
Q4 		$3K Buy
+7
New +$2.3K ﹤0.01% 941

Other funds holding AMPE

Osaic Holdings
Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return
SWM
Sanctuary Wealth Management Pocatello, Idaho $151M AUM 17.94% 1-Year Est. Return
CTB
Country Trust Bank Bloomington, Illinois $5.71B AUM 25.48% 1-Year Est. Return

Newbridge Financial Services Group's AMPE Position: Q2 2024 in Review

Newbridge Financial Services Group sold out of Ampio Pharmaceuticals Inc. (AMPE) in Q2 2024, closing a stake of 35 shares — an estimated $32 sold.

Newbridge Financial Services Group first reported a position in AMPE in Q4 2020 and held it in 14 quarters. The position peaked at $11K in Q3 2021. 6 funds tracked by Wall St. Rank hold AMPE as of Q2 2024.

  • Newbridge Financial Services Group reported no remaining Ampio Pharmaceuticals Inc. position as of Q2 2024 after selling out during the quarter.
  • Newbridge Financial Services Group sold 35 Ampio Pharmaceuticals Inc. shares in Q2 2024, an estimated $32.
  • Newbridge Financial Services Group first reported a position in Ampio Pharmaceuticals Inc. in Q4 2020 and held it in 14 quarters.
  • Newbridge Financial Services Group's Ampio Pharmaceuticals Inc. position peaked at $11K in Q3 2021.
  • 6 funds tracked by Wall St. Rank held Ampio Pharmaceuticals Inc. as of Q2 2024.

Based on Newbridge Financial Services Group's 13F filing for Q2 2024, filed 11 Sep 2024.